GSE49485: Hypoxia transcriptome sequencing of rat brain.
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Chd1
|
ENSRNOG00000014434 | chromodomain helicase DNA binding protein 1 |
Pml
|
ENSRNOG00000008400 | promyelocytic leukemia |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Pml | rn6_v1_chr8_-_63034226_63034226 | 0.88 | 4.8e-02 | Click! |
Chd1 | rn6_v1_chr1_+_57692836_57692983 | 0.80 | 1.1e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr9_+_49479023 | 5.47 |
ENSRNOT00000050922
ENSRNOT00000077111 |
Pou3f3
|
POU class 3 homeobox 3 |
chr7_+_70364813 | 4.49 |
ENSRNOT00000084012
ENSRNOT00000031230 |
Agap2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
chr7_+_130474279 | 4.46 |
ENSRNOT00000092388
|
Shank3
|
SH3 and multiple ankyrin repeat domains 3 |
chr7_+_130474508 | 4.22 |
ENSRNOT00000085191
|
Shank3
|
SH3 and multiple ankyrin repeat domains 3 |
chr19_-_19832812 | 4.01 |
ENSRNOT00000084657
|
Papd5
|
poly(A) RNA polymerase D5, non-canonical |
chr3_+_147585947 | 3.68 |
ENSRNOT00000006833
|
Scrt2
|
scratch family transcriptional repressor 2 |
chr14_-_78902063 | 3.63 |
ENSRNOT00000088469
|
Ppp2r2c
|
protein phosphatase 2, regulatory subunit B, gamma |
chr15_+_51756978 | 3.45 |
ENSRNOT00000024067
|
Egr3
|
early growth response 3 |
chr8_+_114866768 | 3.34 |
ENSRNOT00000076731
|
Wdr82
|
WD repeat domain 82 |
chr3_-_164095878 | 3.13 |
ENSRNOT00000079414
|
B4galt5
|
beta-1,4-galactosyltransferase 5 |
chr20_-_19825150 | 3.10 |
ENSRNOT00000032159
|
Ccdc6
|
coiled-coil domain containing 6 |
chr9_+_17841410 | 3.03 |
ENSRNOT00000031706
|
Tmem151b
|
transmembrane protein 151B |
chr14_+_87312203 | 3.00 |
ENSRNOT00000088032
|
Adcy1
|
adenylate cyclase 1 |
chr17_+_6909728 | 2.96 |
ENSRNOT00000061231
|
LOC681410
|
hypothetical protein LOC681410 |
chr15_+_108908607 | 2.91 |
ENSRNOT00000089455
|
Zic2
|
Zic family member 2 |
chr8_+_117486083 | 2.90 |
ENSRNOT00000027552
ENSRNOT00000088705 |
Prkar2a
|
protein kinase cAMP-dependent type 2 regulatory subunit alpha |
chr10_-_74679858 | 2.82 |
ENSRNOT00000003859
|
Ppm1e
|
protein phosphatase, Mg2+/Mn2+ dependent, 1E |
chr3_+_6211789 | 2.82 |
ENSRNOT00000012892
|
Rxra
|
retinoid X receptor alpha |
chr6_-_132183434 | 2.66 |
ENSRNOT00000079807
|
AABR07065498.1
|
|
chr2_-_77632628 | 2.65 |
ENSRNOT00000073915
|
Basp1
|
brain abundant, membrane attached signal protein 1 |
chr7_+_130498199 | 2.60 |
ENSRNOT00000092684
ENSRNOT00000092431 |
Shank3
|
SH3 and multiple ankyrin repeat domains 3 |
chr6_+_132702448 | 2.60 |
ENSRNOT00000005743
|
Yy1
|
YY1 transcription factor |
chr7_-_12393266 | 2.49 |
ENSRNOT00000021709
|
Efna2
|
ephrin A2 |
chr5_-_172623899 | 2.46 |
ENSRNOT00000080591
|
Ski
|
SKI proto-oncogene |
chr17_-_9695292 | 2.44 |
ENSRNOT00000036162
|
Prr7
|
proline rich 7 (synaptic) |
chr8_-_69466618 | 2.42 |
ENSRNOT00000042925
|
Ids
|
iduronate 2-sulfatase |
chr10_+_67862054 | 2.40 |
ENSRNOT00000031746
|
Cdk5r1
|
cyclin-dependent kinase 5 regulatory subunit 1 |
chr8_+_16287804 | 2.33 |
ENSRNOT00000024691
|
Vkorc1l1
|
vitamin K epoxide reductase complex, subunit 1-like 1 |
chr10_-_105552986 | 2.31 |
ENSRNOT00000014699
|
Ube2o
|
ubiquitin-conjugating enzyme E2O |
chr8_+_127144903 | 2.30 |
ENSRNOT00000013530
|
Eomes
|
eomesodermin |
chr4_-_154043850 | 2.30 |
ENSRNOT00000018902
|
Iqsec3
|
IQ motif and Sec7 domain 3 |
chr19_-_53688597 | 2.29 |
ENSRNOT00000074448
|
Zcchc14
|
zinc finger CCHC-type containing 14 |
chr5_-_82168347 | 2.16 |
ENSRNOT00000084959
ENSRNOT00000084147 |
Astn2
|
astrotactin 2 |
chr3_-_160301552 | 2.15 |
ENSRNOT00000014498
|
Rims4
|
regulating synaptic membrane exocytosis 4 |
chr9_-_110936631 | 2.11 |
ENSRNOT00000064431
|
Fbxl17
|
F-box and leucine-rich repeat protein 17 |
chr17_+_16106137 | 2.10 |
ENSRNOT00000060568
|
Fam120a
|
family with sequence similarity 120A |
chr4_+_146106386 | 2.09 |
ENSRNOT00000008342
|
Slc6a11
|
solute carrier family 6 member 11 |
chr6_-_99783047 | 2.04 |
ENSRNOT00000009028
|
Sptb
|
spectrin, beta, erythrocytic |
chr6_-_27190126 | 2.02 |
ENSRNOT00000068412
ENSRNOT00000013107 |
Kcnk3
|
potassium two pore domain channel subfamily K member 3 |
chr4_-_182844291 | 2.00 |
ENSRNOT00000064320
|
Tmtc1
|
transmembrane and tetratricopeptide repeat containing 1 |
chr10_+_85301875 | 2.00 |
ENSRNOT00000080935
|
Socs7
|
suppressor of cytokine signaling 7 |
chr1_-_52992213 | 2.00 |
ENSRNOT00000033528
|
Prr18
|
proline rich 18 |
chr10_-_85684138 | 1.95 |
ENSRNOT00000017989
|
Pip4k2b
|
phosphatidylinositol-5-phosphate 4-kinase type 2 beta |
chr4_-_153028129 | 1.95 |
ENSRNOT00000074558
|
Cecr6
|
cat eye syndrome chromosome region, candidate 6 |
chr3_-_176644951 | 1.94 |
ENSRNOT00000049961
|
Kcnq2
|
potassium voltage-gated channel subfamily Q member 2 |
chr8_+_116154736 | 1.93 |
ENSRNOT00000021218
|
Cacna2d2
|
calcium voltage-gated channel auxiliary subunit alpha2delta 2 |
chr1_+_100593892 | 1.93 |
ENSRNOT00000027062
|
Kcnc3
|
potassium voltage-gated channel subfamily C member 3 |
chr1_+_100297152 | 1.93 |
ENSRNOT00000026100
|
Shank1
|
SH3 and multiple ankyrin repeat domains 1 |
chr14_-_72380330 | 1.93 |
ENSRNOT00000082653
ENSRNOT00000081878 ENSRNOT00000006727 |
Cpeb2
|
cytoplasmic polyadenylation element binding protein 2 |
chr1_-_212622537 | 1.91 |
ENSRNOT00000025609
|
Sprn
|
shadow of prion protein homolog (zebrafish) |
chr8_+_62723788 | 1.89 |
ENSRNOT00000010620
|
Sema7a
|
semaphorin 7A (John Milton Hagen blood group) |
chr3_-_147865393 | 1.86 |
ENSRNOT00000009852
|
Sox12
|
SRY box 12 |
chr16_-_9709347 | 1.86 |
ENSRNOT00000083933
|
Mapk8
|
mitogen-activated protein kinase 8 |
chr1_-_72366455 | 1.85 |
ENSRNOT00000031786
|
LOC100911196
|
zinc finger protein 865-like |
chr11_+_83048636 | 1.84 |
ENSRNOT00000002408
|
RGD1562339
|
RGD1562339 |
chr7_+_2795901 | 1.79 |
ENSRNOT00000047462
|
Ankrd52
|
ankyrin repeat domain 52 |
chr11_+_83975367 | 1.79 |
ENSRNOT00000058131
|
Camk2n2
|
calcium/calmodulin-dependent protein kinase II inhibitor 2 |
chr1_+_226435979 | 1.79 |
ENSRNOT00000048704
ENSRNOT00000036232 ENSRNOT00000035576 ENSRNOT00000036180 ENSRNOT00000036168 ENSRNOT00000047964 ENSRNOT00000036283 ENSRNOT00000007429 |
Syt7
|
synaptotagmin 7 |
chr3_-_176791960 | 1.78 |
ENSRNOT00000018237
|
Gmeb2
|
glucocorticoid modulatory element binding protein 2 |
chr3_-_14395362 | 1.77 |
ENSRNOT00000092787
|
Rab14
|
RAB14, member RAS oncogene family |
chr6_-_132972511 | 1.77 |
ENSRNOT00000082216
|
Begain
|
brain-enriched guanylate kinase-associated |
chr19_-_25801526 | 1.77 |
ENSRNOT00000003884
|
Nacc1
|
nucleus accumbens associated 1 |
chr4_+_13405136 | 1.77 |
ENSRNOT00000091004
|
Gnai1
|
G protein subunit alpha i1 |
chr1_+_100593680 | 1.74 |
ENSRNOT00000078153
ENSRNOT00000027063 |
Kcnc3
|
potassium voltage-gated channel subfamily C member 3 |
chr10_-_61744976 | 1.74 |
ENSRNOT00000079926
ENSRNOT00000092314 ENSRNOT00000034298 |
Sgsm2
|
small G protein signaling modulator 2 |
chr2_+_43266739 | 1.74 |
ENSRNOT00000087031
|
Mier3
|
mesoderm induction early response 1, family member 3 |
chr8_+_48925604 | 1.71 |
ENSRNOT00000077445
|
Ddx6
|
DEAD-box helicase 6 |
chr3_+_161425988 | 1.70 |
ENSRNOT00000065184
|
Slc12a5
|
solute carrier family 12 member 5 |
chr7_-_67116980 | 1.69 |
ENSRNOT00000005798
|
Ppm1h
|
protein phosphatase, Mg2+/Mn2+ dependent, 1H |
chr3_+_71114100 | 1.68 |
ENSRNOT00000088549
ENSRNOT00000006961 |
Itgav
|
integrin subunit alpha V |
chr10_-_38838272 | 1.67 |
ENSRNOT00000089495
|
Sowaha
|
sosondowah ankyrin repeat domain family member A |
chr1_-_101046208 | 1.66 |
ENSRNOT00000091711
|
Prr12
|
proline rich 12 |
chr17_-_84488480 | 1.66 |
ENSRNOT00000000158
ENSRNOT00000075983 |
Nebl
|
nebulette |
chr15_+_15275541 | 1.65 |
ENSRNOT00000012153
|
Cadps
|
calcium dependent secretion activator |
chr16_+_2743823 | 1.65 |
ENSRNOT00000087873
|
Arhgef3
|
Rho guanine nucleotide exchange factor 3 |
chr1_-_4011511 | 1.64 |
ENSRNOT00000040559
|
Stxbp5
|
syntaxin binding protein 5 |
chr12_+_660011 | 1.63 |
ENSRNOT00000040830
|
Pds5b
|
PDS5 cohesin associated factor B |
chr10_+_55940533 | 1.63 |
ENSRNOT00000012061
|
RGD1563441
|
similar to RIKEN cDNA A030009H04 |
chr20_-_47910375 | 1.61 |
ENSRNOT00000000348
|
Sobp
|
sine oculis binding protein homolog |
chr12_-_9331195 | 1.60 |
ENSRNOT00000044134
|
Pan3
|
PAN3 poly(A) specific ribonuclease subunit |
chr2_-_115891097 | 1.59 |
ENSRNOT00000013191
|
Skil
|
SKI-like proto-oncogene |
chr1_-_198460126 | 1.59 |
ENSRNOT00000082940
ENSRNOT00000086019 |
Maz
|
MYC associated zinc finger protein |
chr1_+_282134981 | 1.56 |
ENSRNOT00000036203
|
Nanos1
|
nanos C2HC-type zinc finger 1 |
chr1_+_144831523 | 1.55 |
ENSRNOT00000039748
|
Mex3b
|
mex-3 RNA binding family member B |
chr1_-_57815038 | 1.55 |
ENSRNOT00000075401
|
Rgmb
|
repulsive guidance molecule family member B |
chr1_-_166911694 | 1.54 |
ENSRNOT00000066915
|
Inppl1
|
inositol polyphosphate phosphatase-like 1 |
chr19_-_55490426 | 1.51 |
ENSRNOT00000081800
|
Cbfa2t3
|
CBFA2/RUNX1 translocation partner 3 |
chr15_+_120372 | 1.50 |
ENSRNOT00000007828
|
Dlg5
|
discs large MAGUK scaffold protein 5 |
chr9_+_70133969 | 1.50 |
ENSRNOT00000040525
|
Adam23
|
ADAM metallopeptidase domain 23 |
chr3_-_153893847 | 1.49 |
ENSRNOT00000085938
|
LOC100911769
|
band 4.1-like protein 1-like |
chr12_-_30304036 | 1.49 |
ENSRNOT00000001218
|
Nupr2
|
nuclear protein 2, transcriptional regulator |
chr20_-_31072469 | 1.49 |
ENSRNOT00000082448
|
Eif4ebp2
|
eukaryotic translation initiation factor 4E binding protein 2 |
chr18_-_63357194 | 1.47 |
ENSRNOT00000089408
ENSRNOT00000066103 |
Spire1
|
spire-type actin nucleation factor 1 |
chr2_-_165739874 | 1.46 |
ENSRNOT00000014384
|
Kpna4
|
karyopherin subunit alpha 4 |
chr19_-_57192095 | 1.45 |
ENSRNOT00000058080
|
Pgbd5
|
piggyBac transposable element derived 5 |
chr9_+_10013854 | 1.43 |
ENSRNOT00000077653
ENSRNOT00000072033 |
Khsrp
|
KH-type splicing regulatory protein |
chr10_-_4249739 | 1.42 |
ENSRNOT00000003150
|
Snx29
|
sorting nexin 29 |
chr8_-_115981910 | 1.42 |
ENSRNOT00000019867
|
Dock3
|
dedicator of cyto-kinesis 3 |
chr18_+_27657628 | 1.42 |
ENSRNOT00000026303
|
Egr1
|
early growth response 1 |
chr11_+_16826399 | 1.42 |
ENSRNOT00000050701
|
Cxadr
|
coxsackie virus and adenovirus receptor |
chr20_+_5535432 | 1.41 |
ENSRNOT00000040859
|
Syngap1
|
synaptic Ras GTPase activating protein 1 |
chr13_+_92569785 | 1.41 |
ENSRNOT00000082700
|
Fmn2
|
formin 2 |
chr5_-_86696388 | 1.41 |
ENSRNOT00000007812
|
Megf9
|
multiple EGF-like-domains 9 |
chr10_+_14547172 | 1.41 |
ENSRNOT00000092043
|
Unkl
|
unkempt family like zinc finger |
chr8_+_119566509 | 1.40 |
ENSRNOT00000028633
|
Trank1
|
tetratricopeptide repeat and ankyrin repeat containing 1 |
chr12_+_23151180 | 1.40 |
ENSRNOT00000059486
|
Cux1
|
cut-like homeobox 1 |
chrX_-_123515720 | 1.40 |
ENSRNOT00000092343
|
Nkrf
|
NFKB repressing factor |
chr10_+_59360765 | 1.39 |
ENSRNOT00000036278
|
Zzef1
|
zinc finger ZZ-type and EF-hand domain containing 1 |
chr20_+_6205903 | 1.38 |
ENSRNOT00000092333
ENSRNOT00000092655 |
Kctd20
|
potassium channel tetramerization domain containing 20 |
chr7_+_11033317 | 1.38 |
ENSRNOT00000007498
|
Gna11
|
guanine nucleotide binding protein, alpha 11 |
chr8_+_114867062 | 1.38 |
ENSRNOT00000074771
|
Wdr82
|
WD repeat domain 82 |
chr1_+_165625350 | 1.37 |
ENSRNOT00000087534
|
Rab6a
|
RAB6A, member RAS oncogene family |
chr10_+_70627401 | 1.37 |
ENSRNOT00000076897
|
Rasl10b
|
RAS-like, family 10, member B |
chr10_-_88754829 | 1.36 |
ENSRNOT00000026354
|
Stat5b
|
signal transducer and activator of transcription 5B |
chr2_-_191986170 | 1.35 |
ENSRNOT00000090155
|
AABR07012274.1
|
|
chr7_+_80713321 | 1.34 |
ENSRNOT00000091355
ENSRNOT00000078354 |
Oxr1
|
oxidation resistance 1 |
chr7_+_2875909 | 1.34 |
ENSRNOT00000028244
|
Smarcc2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2 |
chr14_-_82287706 | 1.34 |
ENSRNOT00000080695
|
Fgfr3
|
fibroblast growth factor receptor 3 |
chr7_+_130532435 | 1.33 |
ENSRNOT00000092672
ENSRNOT00000092535 |
Shank3
|
SH3 and multiple ankyrin repeat domains 3 |
chr19_+_55094585 | 1.33 |
ENSRNOT00000068452
|
Zfpm1
|
zinc finger protein, multitype 1 |
chr7_+_11152038 | 1.32 |
ENSRNOT00000006168
|
Nfic
|
nuclear factor I/C |
chr6_+_9483594 | 1.32 |
ENSRNOT00000089272
|
AABR07062799.2
|
|
chr9_-_28972835 | 1.32 |
ENSRNOT00000086967
ENSRNOT00000079684 |
Rims1
|
regulating synaptic membrane exocytosis 1 |
chr7_-_123445613 | 1.32 |
ENSRNOT00000070937
|
Shisa8
|
shisa family member 8 |
chr11_+_71796282 | 1.32 |
ENSRNOT00000087489
|
Fbxo45
|
F-box protein 45 |
chr10_-_10881844 | 1.31 |
ENSRNOT00000087118
ENSRNOT00000004416 |
Mgrn1
|
mahogunin ring finger 1 |
chr7_+_27309966 | 1.31 |
ENSRNOT00000031871
|
Nt5dc3
|
5'-nucleotidase domain containing 3 |
chr1_+_251421596 | 1.31 |
ENSRNOT00000028143
|
Pten
|
phosphatase and tensin homolog |
chr16_-_19225037 | 1.30 |
ENSRNOT00000019052
|
Klf2
|
Kruppel-like factor 2 |
chr2_+_226900619 | 1.29 |
ENSRNOT00000019638
|
Pde5a
|
phosphodiesterase 5A |
chr9_+_53627208 | 1.29 |
ENSRNOT00000083487
|
Mfsd6
|
major facilitator superfamily domain containing 6 |
chr2_-_211831551 | 1.28 |
ENSRNOT00000039225
ENSRNOT00000090561 |
Fam102b
|
family with sequence similarity 102, member B |
chr10_+_36098051 | 1.28 |
ENSRNOT00000083971
|
Adamts2
|
ADAM metallopeptidase with thrombospondin type 1 motif, 2 |
chr10_-_55642681 | 1.27 |
ENSRNOT00000057157
|
AC129753.1
|
|
chr3_+_161433410 | 1.27 |
ENSRNOT00000024657
|
Slc12a5
|
solute carrier family 12 member 5 |
chr5_-_156811650 | 1.27 |
ENSRNOT00000068065
|
Fam43b
|
family with sequence similarity 43, member B |
chr12_-_40417654 | 1.26 |
ENSRNOT00000072481
|
Brap
|
BRCA1 associated protein |
chr17_-_60946426 | 1.26 |
ENSRNOT00000058852
|
Wac
|
WW domain containing adaptor with coiled-coil |
chr17_+_4846789 | 1.25 |
ENSRNOT00000073271
|
Gas1
|
growth arrest-specific 1 |
chr1_+_221792221 | 1.25 |
ENSRNOT00000054828
|
Nrxn2
|
neurexin 2 |
chr12_-_2555164 | 1.23 |
ENSRNOT00000084460
ENSRNOT00000061821 |
Map2k7
|
mitogen activated protein kinase kinase 7 |
chr9_+_94980409 | 1.23 |
ENSRNOT00000035338
|
Dgkd
|
diacylglycerol kinase, delta |
chr1_-_281874456 | 1.23 |
ENSRNOT00000084760
ENSRNOT00000050617 |
Cacul1
|
CDK2-associated, cullin domain 1 |
chr5_+_28850950 | 1.23 |
ENSRNOT00000009759
|
Tmem64
|
transmembrane protein 64 |
chr6_-_115616766 | 1.23 |
ENSRNOT00000006143
ENSRNOT00000045870 |
Sel1l
|
SEL1L ERAD E3 ligase adaptor subunit |
chr5_-_109621170 | 1.21 |
ENSRNOT00000093007
|
Elavl2
|
ELAV like RNA binding protein 2 |
chr10_-_64642292 | 1.20 |
ENSRNOT00000084670
|
Abr
|
active BCR-related |
chr9_-_41337498 | 1.18 |
ENSRNOT00000039480
|
Fam168b
|
family with sequence similarity 168, member B |
chr2_-_43999107 | 1.18 |
ENSRNOT00000065473
|
LOC100912399
|
mitogen-activated protein kinase kinase kinase 1-like |
chr6_-_65319527 | 1.18 |
ENSRNOT00000005618
|
Stxbp6
|
syntaxin binding protein 6 |
chr16_+_83824430 | 1.17 |
ENSRNOT00000032918
|
Irs2
|
insulin receptor substrate 2 |
chr5_-_153625869 | 1.17 |
ENSRNOT00000024464
|
Clic4
|
chloride intracellular channel 4 |
chr10_+_67325347 | 1.17 |
ENSRNOT00000079002
ENSRNOT00000085914 |
Suz12
|
suppressor of zeste 12 homolog (Drosophila) |
chr8_-_6203515 | 1.16 |
ENSRNOT00000087278
ENSRNOT00000031189 ENSRNOT00000008074 ENSRNOT00000085285 ENSRNOT00000007866 |
Yap1
|
yes-associated protein 1 |
chr15_-_57805184 | 1.16 |
ENSRNOT00000000168
|
Cog3
|
component of oligomeric golgi complex 3 |
chr16_+_62483761 | 1.16 |
ENSRNOT00000058805
|
Wrn
|
Werner syndrome RecQ like helicase |
chr1_+_266953139 | 1.15 |
ENSRNOT00000054696
|
Neurl1
|
neuralized E3 ubiquitin protein ligase 1 |
chr1_-_4011161 | 1.15 |
ENSRNOT00000044778
|
Stxbp5
|
syntaxin binding protein 5 |
chr5_+_128923934 | 1.15 |
ENSRNOT00000064145
|
Eps15
|
epidermal growth factor receptor pathway substrate 15 |
chr10_-_5196892 | 1.14 |
ENSRNOT00000083982
|
Clec16a
|
C-type lectin domain family 16, member A |
chr6_-_110904288 | 1.13 |
ENSRNOT00000014645
|
Irf2bpl
|
interferon regulatory factor 2 binding protein-like |
chr3_-_58181971 | 1.13 |
ENSRNOT00000002076
|
Dlx2
|
distal-less homeobox 2 |
chr19_+_10119253 | 1.12 |
ENSRNOT00000017971
|
Zfp319
|
zinc finger protein 319 |
chr2_+_22909569 | 1.12 |
ENSRNOT00000073871
|
Homer1
|
homer scaffolding protein 1 |
chr10_-_108196217 | 1.11 |
ENSRNOT00000075440
|
Cbx4
|
chromobox 4 |
chr10_-_85574889 | 1.11 |
ENSRNOT00000072274
|
LOC691153
|
hypothetical protein LOC691153 |
chr16_-_60208462 | 1.11 |
ENSRNOT00000015203
|
Mfhas1
|
malignant fibrous histiocytoma amplified sequence 1 |
chr1_+_113034227 | 1.11 |
ENSRNOT00000081831
ENSRNOT00000077877 ENSRNOT00000077594 |
Gabrb3
|
gamma-aminobutyric acid type A receptor beta 3 subunit |
chr14_+_60857989 | 1.11 |
ENSRNOT00000034411
|
Ccdc149
|
coiled-coil domain containing 149 |
chr1_-_90246265 | 1.11 |
ENSRNOT00000078585
ENSRNOT00000030186 |
Lsm14a
|
LSM14A mRNA processing body assembly factor |
chr13_-_110864469 | 1.10 |
ENSRNOT00000073588
|
Rcor3
|
REST corepressor 3 |
chr15_-_12513931 | 1.10 |
ENSRNOT00000010103
|
Atxn7
|
ataxin 7 |
chr12_-_38691075 | 1.10 |
ENSRNOT00000084192
|
Bcl7a
|
BCL tumor suppressor 7A |
chr1_-_125967756 | 1.10 |
ENSRNOT00000031488
|
Fam189a1
|
family with sequence similarity 189, member A1 |
chr16_+_20740826 | 1.10 |
ENSRNOT00000038057
|
Crtc1
|
CREB regulated transcription coactivator 1 |
chr10_-_82197848 | 1.10 |
ENSRNOT00000081307
|
Cacna1g
|
calcium voltage-gated channel subunit alpha1 G |
chr7_+_11737293 | 1.10 |
ENSRNOT00000046059
|
Lingo3
|
leucine rich repeat and Ig domain containing 3 |
chr2_+_205783252 | 1.09 |
ENSRNOT00000025633
ENSRNOT00000025600 |
Trim33
|
tripartite motif-containing 33 |
chr3_+_151310598 | 1.09 |
ENSRNOT00000092194
|
Mmp24
|
matrix metallopeptidase 24 |
chr1_+_225015616 | 1.09 |
ENSRNOT00000026416
|
Hnrnpul2
|
heterogeneous nuclear ribonucleoprotein U-like 2 |
chr2_-_84608712 | 1.09 |
ENSRNOT00000028561
|
March6
|
membrane associated ring-CH-type finger 6 |
chr4_+_142453013 | 1.09 |
ENSRNOT00000056573
|
AABR07061755.1
|
|
chr5_+_120250616 | 1.09 |
ENSRNOT00000070967
|
Ak4
|
adenylate kinase 4 |
chr17_-_23923792 | 1.08 |
ENSRNOT00000018739
|
Gfod1
|
glucose-fructose oxidoreductase domain containing 1 |
chr15_+_19547871 | 1.08 |
ENSRNOT00000036235
|
Gpr137c
|
G protein-coupled receptor 137C |
chr1_+_15412603 | 1.08 |
ENSRNOT00000051496
ENSRNOT00000067070 |
Map3k5
|
mitogen-activated protein kinase kinase kinase 5 |
chr1_+_233382708 | 1.08 |
ENSRNOT00000019174
|
Gnaq
|
G protein subunit alpha q |
chr10_+_63829807 | 1.07 |
ENSRNOT00000006407
|
Crk
|
CRK proto-oncogene, adaptor protein |
chr11_-_88273254 | 1.07 |
ENSRNOT00000002533
|
Mapk1
|
mitogen activated protein kinase 1 |
chr16_-_69132584 | 1.07 |
ENSRNOT00000017776
|
Adgra2
|
adhesion G protein-coupled receptor A2 |
chr3_-_59688692 | 1.06 |
ENSRNOT00000078752
|
Sp3
|
Sp3 transcription factor |
chr9_-_63637677 | 1.06 |
ENSRNOT00000049259
|
Satb2
|
SATB homeobox 2 |
chr7_-_126465723 | 1.05 |
ENSRNOT00000021196
|
Wnt7b
|
wingless-type MMTV integration site family, member 7B |
chr3_+_116899878 | 1.05 |
ENSRNOT00000090802
ENSRNOT00000066101 |
Sema6d
|
semaphorin 6D |
chr10_+_105393072 | 1.05 |
ENSRNOT00000013359
|
Ubald2
|
UBA-like domain containing 2 |
chr10_+_62674561 | 1.04 |
ENSRNOT00000019946
ENSRNOT00000056110 |
Ankrd13b
|
ankyrin repeat domain 13B |
chr4_-_115157263 | 1.04 |
ENSRNOT00000015296
|
Tet3
|
tet methylcytosine dioxygenase 3 |
chr5_-_151709877 | 1.04 |
ENSRNOT00000080602
|
Trnp1
|
TMF1-regulated nuclear protein 1 |
chr16_+_19051965 | 1.04 |
ENSRNOT00000016399
|
Slc35e1
|
solute carrier family 35, member E1 |
chr8_-_115621394 | 1.03 |
ENSRNOT00000018995
|
Rbm15b
|
RNA binding motif protein 15B |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 12.6 | GO:1904717 | regulation of AMPA glutamate receptor clustering(GO:1904717) |
1.5 | 6.1 | GO:0072218 | ascending thin limb development(GO:0072021) metanephric ascending thin limb development(GO:0072218) |
1.0 | 3.1 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.9 | 2.7 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.8 | 3.2 | GO:0021586 | pons maturation(GO:0021586) |
0.7 | 2.6 | GO:0050893 | sensory processing(GO:0050893) |
0.7 | 2.0 | GO:0031632 | positive regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031632) |
0.6 | 2.6 | GO:0034696 | response to prostaglandin F(GO:0034696) |
0.6 | 2.4 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.6 | 4.9 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.6 | 1.8 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
0.6 | 1.8 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
0.6 | 1.8 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.6 | 1.7 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.6 | 2.2 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.6 | 1.7 | GO:0098749 | cerebellar neuron development(GO:0098749) |
0.6 | 1.7 | GO:0071691 | cardiac muscle thin filament assembly(GO:0071691) |
0.5 | 1.6 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
0.5 | 1.5 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.5 | 1.9 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.5 | 1.9 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.5 | 1.4 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.5 | 1.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.5 | 2.8 | GO:0097338 | response to clozapine(GO:0097338) |
0.5 | 1.9 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.5 | 1.4 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.5 | 1.4 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.4 | 1.3 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.4 | 1.3 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.4 | 3.1 | GO:0045176 | apical protein localization(GO:0045176) |
0.4 | 1.7 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.4 | 1.7 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.4 | 1.7 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.4 | 1.7 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.4 | 1.5 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.4 | 1.1 | GO:0072054 | renal outer medulla development(GO:0072054) |
0.4 | 3.0 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.4 | 1.1 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.4 | 1.5 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.4 | 0.7 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.4 | 4.4 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.4 | 1.1 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.4 | 1.1 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.3 | 1.0 | GO:0044725 | chromatin reprogramming in the zygote(GO:0044725) |
0.3 | 2.1 | GO:0010045 | response to nickel cation(GO:0010045) |
0.3 | 1.0 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.3 | 1.4 | GO:1990859 | response to endothelin(GO:1990839) cellular response to endothelin(GO:1990859) |
0.3 | 1.7 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.3 | 0.7 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.3 | 3.6 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.3 | 1.0 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.3 | 0.3 | GO:1905072 | cardiac jelly development(GO:1905072) |
0.3 | 1.0 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.3 | 1.3 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.3 | 0.9 | GO:0003249 | cell proliferation involved in heart valve morphogenesis(GO:0003249) regulation of cell proliferation involved in heart valve morphogenesis(GO:0003250) |
0.3 | 1.2 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.3 | 1.2 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.3 | 2.4 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.3 | 1.8 | GO:0034475 | U4 snRNA 3'-end processing(GO:0034475) DNA deamination(GO:0045006) polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.3 | 4.7 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.3 | 1.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.3 | 0.6 | GO:0007037 | vacuolar phosphate transport(GO:0007037) positive regulation of parathyroid hormone secretion(GO:2000830) |
0.3 | 0.6 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.3 | 0.9 | GO:0046154 | eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) rhodopsin metabolic process(GO:0046154) |
0.3 | 1.2 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.3 | 0.3 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) |
0.3 | 2.5 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.3 | 0.3 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.3 | 0.8 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.3 | 0.3 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.3 | 3.0 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.3 | 0.8 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.3 | 0.8 | GO:0060082 | eye blink reflex(GO:0060082) |
0.3 | 3.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.3 | 0.8 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.3 | 5.1 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.3 | 0.8 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.3 | 1.6 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.3 | 1.3 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.3 | 0.5 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) regulation of skeletal muscle hypertrophy(GO:1904204) |
0.3 | 1.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.3 | 0.5 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.3 | 1.8 | GO:1990785 | response to water-immersion restraint stress(GO:1990785) |
0.3 | 1.3 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.3 | 0.8 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.3 | 0.5 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.3 | 0.8 | GO:1900135 | positive regulation of renin secretion into blood stream(GO:1900135) |
0.3 | 1.5 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
0.2 | 2.2 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.2 | 0.7 | GO:1902380 | positive regulation of mRNA cleavage(GO:0031439) positive regulation of endoribonuclease activity(GO:1902380) positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904722) |
0.2 | 1.2 | GO:0099628 | receptor diffusion trapping(GO:0098953) postsynaptic neurotransmitter receptor diffusion trapping(GO:0098970) neurotransmitter receptor diffusion trapping(GO:0099628) |
0.2 | 1.4 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.2 | 0.2 | GO:0097324 | melanocyte migration(GO:0097324) |
0.2 | 1.6 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
0.2 | 1.9 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 0.9 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.2 | 0.7 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.2 | 3.2 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 0.7 | GO:0061188 | negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.2 | 0.9 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.2 | 1.1 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.2 | 0.4 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.2 | 1.6 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.2 | 4.7 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.2 | 0.7 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.2 | 1.3 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.2 | 0.4 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.2 | 0.6 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.2 | 1.5 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.2 | 0.4 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.2 | 0.4 | GO:0045575 | basophil activation(GO:0045575) |
0.2 | 0.6 | GO:1903406 | regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
0.2 | 0.9 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.2 | 0.6 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
0.2 | 0.6 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.2 | 0.8 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.2 | 1.5 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.2 | 0.6 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.2 | 0.8 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.2 | 0.8 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 0.8 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.2 | 0.4 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
0.2 | 0.6 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.2 | 1.2 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.2 | 0.6 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
0.2 | 1.5 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.2 | 1.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.2 | 0.4 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
0.2 | 0.6 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.2 | 0.4 | GO:0043316 | cytotoxic T cell degranulation(GO:0043316) |
0.2 | 0.9 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.2 | 1.1 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.2 | 2.2 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.2 | 0.5 | GO:0015827 | tryptophan transport(GO:0015827) |
0.2 | 2.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 1.3 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.2 | 0.2 | GO:1902837 | amino acid import across plasma membrane(GO:0089718) amino acid import into cell(GO:1902837) |
0.2 | 0.5 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.2 | 0.5 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.2 | 0.5 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.2 | 2.7 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.2 | 0.2 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.2 | 3.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 0.9 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
0.2 | 1.0 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.2 | 1.6 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.2 | 2.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 0.3 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.2 | 0.5 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
0.2 | 1.0 | GO:0061439 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.2 | 0.5 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.2 | 1.0 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.2 | 0.2 | GO:0090292 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.2 | 1.4 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.2 | 0.5 | GO:0061744 | motor behavior(GO:0061744) |
0.2 | 1.0 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.2 | 0.3 | GO:1904587 | response to glycoprotein(GO:1904587) |
0.2 | 0.5 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.2 | 0.2 | GO:0018307 | enzyme active site formation(GO:0018307) |
0.2 | 1.5 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.2 | 1.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 0.3 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.2 | 0.7 | GO:1904616 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
0.2 | 0.5 | GO:0060816 | random inactivation of X chromosome(GO:0060816) regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.2 | 0.7 | GO:1901073 | glucosamine-containing compound biosynthetic process(GO:1901073) |
0.2 | 2.0 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.2 | 0.5 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
0.2 | 0.8 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.2 | 0.8 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.2 | 0.6 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.2 | 0.3 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.2 | 0.2 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.2 | 1.3 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.2 | 0.3 | GO:0021590 | cerebellum maturation(GO:0021590) |
0.2 | 0.8 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 0.6 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.2 | 1.1 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.2 | 1.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.2 | 0.5 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) |
0.2 | 0.5 | GO:1903935 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
0.2 | 0.5 | GO:1904938 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.1 | 0.7 | GO:0097350 | neutrophil clearance(GO:0097350) |
0.1 | 0.9 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.4 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.1 | 1.0 | GO:0071000 | response to magnetism(GO:0071000) |
0.1 | 0.7 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 0.6 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.6 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.3 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.1 | 0.3 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.1 | 1.6 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.4 | GO:1901219 | regulation of cardiac chamber morphogenesis(GO:1901219) negative regulation of cardiac chamber morphogenesis(GO:1901220) |
0.1 | 0.4 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
0.1 | 1.3 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.6 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.1 | 1.0 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 | 0.4 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.1 | 0.1 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.1 | 0.8 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.1 | 0.3 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.1 | 0.3 | GO:0036446 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
0.1 | 0.6 | GO:0035106 | operant conditioning(GO:0035106) |
0.1 | 1.8 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.6 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 1.0 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.7 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.7 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 2.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.7 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 1.2 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.3 | GO:0051695 | actin filament uncapping(GO:0051695) |
0.1 | 0.4 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.1 | 0.3 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
0.1 | 0.1 | GO:1902994 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
0.1 | 0.5 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.3 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.1 | 0.7 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 0.4 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.1 | 4.1 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 0.7 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 0.5 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.1 | 0.4 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.3 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.8 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.1 | 1.0 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.1 | 0.1 | GO:0044330 | canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) |
0.1 | 0.5 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 0.6 | GO:1903960 | negative regulation of anion channel activity(GO:0010360) negative regulation of anion transmembrane transport(GO:1903960) |
0.1 | 0.1 | GO:0006228 | UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
0.1 | 0.9 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.1 | 1.3 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 0.5 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
0.1 | 0.3 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 0.5 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 2.0 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.1 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.1 | 0.1 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.1 | 0.4 | GO:1903699 | tarsal gland development(GO:1903699) |
0.1 | 0.4 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.1 | 0.4 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.1 | 0.5 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.1 | 0.2 | GO:1901143 | insulin catabolic process(GO:1901143) |
0.1 | 0.9 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.1 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
0.1 | 0.7 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.4 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
0.1 | 0.5 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.1 | 1.5 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 0.2 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.7 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 1.0 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.5 | GO:1990523 | bone regeneration(GO:1990523) |
0.1 | 0.1 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
0.1 | 3.2 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.1 | 0.2 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
0.1 | 0.3 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.1 | 0.3 | GO:0006408 | snRNA export from nucleus(GO:0006408) |
0.1 | 0.6 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 3.6 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 1.1 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.1 | 0.6 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.1 | 0.2 | GO:0032763 | mast cell cytokine production(GO:0032762) regulation of mast cell cytokine production(GO:0032763) |
0.1 | 0.5 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.1 | 1.4 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 2.6 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 1.4 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 1.7 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 0.1 | GO:1990478 | response to ultrasound(GO:1990478) |
0.1 | 0.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 0.2 | GO:0016240 | autophagosome docking(GO:0016240) |
0.1 | 0.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 1.8 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.1 | 0.4 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.1 | 0.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.1 | 0.5 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 0.5 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.1 | 1.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.3 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 0.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.3 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.6 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.1 | 0.3 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.6 | GO:1904647 | response to rotenone(GO:1904647) |
0.1 | 0.2 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.1 | 0.1 | GO:0048389 | intermediate mesoderm development(GO:0048389) pattern specification involved in mesonephros development(GO:0061227) anterior/posterior pattern specification involved in kidney development(GO:0072098) |
0.1 | 0.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.4 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 1.6 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.1 | 0.3 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 0.6 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.1 | 0.3 | GO:0021873 | neuroblast division in subventricular zone(GO:0021849) forebrain neuroblast division(GO:0021873) |
0.1 | 1.2 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 0.3 | GO:1904009 | cellular response to monosodium glutamate(GO:1904009) |
0.1 | 0.3 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 0.6 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.4 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.1 | 4.2 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 0.2 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
0.1 | 0.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.4 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.1 | 0.7 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.1 | 0.3 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.1 | 1.2 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.5 | GO:0070836 | caveola assembly(GO:0070836) |
0.1 | 0.2 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.1 | 0.3 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.1 | 0.2 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.1 | 0.4 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.1 | 1.0 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.6 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.2 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.1 | 0.3 | GO:1902287 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.1 | 0.1 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.1 | 0.9 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 1.6 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.1 | 0.3 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.1 | 0.9 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.1 | 0.8 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.2 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 0.4 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
0.1 | 0.2 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.1 | 0.3 | GO:1905050 | positive regulation of metallopeptidase activity(GO:1905050) |
0.1 | 0.3 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.1 | 0.2 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 0.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 0.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.3 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.1 | 0.1 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.1 | 0.3 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.1 | 0.8 | GO:0001711 | endodermal cell fate commitment(GO:0001711) |
0.1 | 0.5 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.1 | 2.7 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.5 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.1 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.4 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.1 | 0.3 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.1 | 0.8 | GO:0098880 | maintenance of postsynaptic specialization structure(GO:0098880) maintenance of postsynaptic density structure(GO:0099562) |
0.1 | 1.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.1 | 0.1 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.1 | 0.3 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 0.4 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.1 | 0.2 | GO:1904209 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
0.1 | 1.6 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.2 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.1 | 1.2 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.4 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.1 | 1.5 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.2 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
0.1 | 0.3 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.1 | 0.9 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.3 | GO:0031179 | peptide modification(GO:0031179) |
0.1 | 0.6 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.1 | 0.5 | GO:0071233 | cellular response to leucine(GO:0071233) |
0.1 | 0.1 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.1 | 0.4 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.1 | 0.2 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.1 | 0.5 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.9 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.1 | 0.7 | GO:0042048 | olfactory behavior(GO:0042048) |
0.1 | 0.3 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.1 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.1 | 0.4 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.1 | 1.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.3 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.1 | 0.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.2 | GO:2000836 | positive regulation of androgen secretion(GO:2000836) positive regulation of testosterone secretion(GO:2000845) |
0.1 | 0.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 0.2 | GO:0060849 | lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
0.1 | 2.4 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.8 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.1 | 0.3 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.1 | 0.4 | GO:0046959 | habituation(GO:0046959) |
0.1 | 0.5 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.1 | 1.5 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.4 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.1 | 0.8 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 1.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 1.0 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 1.0 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.1 | 0.1 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.1 | 0.2 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
0.1 | 0.5 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.1 | 0.2 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.1 | 0.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.6 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 0.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.1 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.1 | 0.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 0.4 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.1 | 0.1 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.1 | 1.1 | GO:0070076 | histone lysine demethylation(GO:0070076) |
0.1 | 0.4 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 0.2 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 1.4 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.2 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.1 | 0.6 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 1.0 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
0.1 | 0.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.5 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.1 | GO:0014841 | skeletal muscle satellite cell proliferation(GO:0014841) |
0.1 | 0.3 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.2 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.1 | 0.1 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 2.7 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.1 | 0.1 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.1 | 0.5 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.1 | 0.3 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.1 | 0.1 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) regulation of nonmotile primary cilium assembly(GO:1902855) |
0.1 | 0.1 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
0.1 | 0.9 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.8 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.8 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.3 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 0.1 | GO:0061010 | gall bladder development(GO:0061010) |
0.1 | 1.2 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.1 | 0.5 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.1 | 0.2 | GO:0006649 | phospholipid transfer to membrane(GO:0006649) NAD transport(GO:0043132) |
0.1 | 0.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.1 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.1 | 1.9 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.1 | GO:1905006 | negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905006) |
0.1 | 0.2 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.3 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.1 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.3 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.1 | 0.7 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.5 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 | 0.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.3 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.7 | GO:0042533 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.1 | 0.6 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.6 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 0.3 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.1 | 0.2 | GO:1905247 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.1 | 0.1 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.1 | 0.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 0.1 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.1 | 0.5 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.6 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 0.5 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.2 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.1 | 0.3 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 1.8 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.1 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.1 | 0.2 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.1 | 1.1 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.6 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.1 | 0.7 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.1 | 0.4 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.1 | 0.3 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.1 | 0.2 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.1 | 0.2 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.1 | 0.3 | GO:0036146 | cellular response to mycotoxin(GO:0036146) |
0.1 | 0.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.2 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.1 | 0.3 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.1 | 0.1 | GO:0015820 | leucine transport(GO:0015820) |
0.1 | 0.1 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.1 | 0.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.1 | 0.2 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 0.2 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.1 | 0.2 | GO:0042357 | thiamine metabolic process(GO:0006772) thiamine diphosphate metabolic process(GO:0042357) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.1 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.1 | 0.1 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.1 | 0.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.2 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 0.3 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) |
0.1 | 0.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.3 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.5 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.2 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.2 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
0.1 | 0.2 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.1 | 0.2 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.4 | GO:0046710 | GDP metabolic process(GO:0046710) |
0.1 | 0.1 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.1 | 0.4 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 0.2 | GO:0035600 | tRNA methylthiolation(GO:0035600) |
0.1 | 1.1 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 1.0 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.2 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.1 | 0.2 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
0.1 | 0.1 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.1 | 0.3 | GO:2000322 | regulation of glucocorticoid receptor signaling pathway(GO:2000322) |
0.1 | 0.1 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.1 | 0.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.1 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
0.1 | 0.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.2 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
0.1 | 0.2 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.1 | 0.3 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.0 | 0.2 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.0 | 0.3 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.1 | GO:0046016 | positive regulation of transcription by glucose(GO:0046016) |
0.0 | 0.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.1 | GO:1901423 | response to benzene(GO:1901423) |
0.0 | 0.1 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
0.0 | 0.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.8 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.0 | 0.4 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.0 | 0.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.2 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.0 | 0.2 | GO:1903624 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
0.0 | 1.5 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.0 | 0.7 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.6 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.0 | 0.0 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) |
0.0 | 0.3 | GO:0090650 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.0 | 0.2 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.0 | 0.2 | GO:0006272 | leading strand elongation(GO:0006272) |
0.0 | 0.2 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.0 | 0.2 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.0 | 0.1 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.0 | 0.2 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.1 | GO:0080144 | amino acid homeostasis(GO:0080144) |
0.0 | 0.2 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.0 | 0.2 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
0.0 | 0.1 | GO:0090172 | microtubule cytoskeleton organization involved in homologous chromosome segregation(GO:0090172) |
0.0 | 0.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.0 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.0 | 0.4 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.0 | 0.0 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.0 | 0.4 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
0.0 | 0.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.0 | 0.3 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.1 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.3 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 0.1 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.0 | 0.1 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.0 | 0.6 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.9 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.4 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.0 | 0.1 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
0.0 | 0.0 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.0 | 0.1 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
0.0 | 0.1 | GO:0060956 | cardiac endothelial cell differentiation(GO:0003348) endocardial cell differentiation(GO:0060956) |
0.0 | 0.1 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.0 | 0.2 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.0 | 0.1 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.0 | 0.1 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.0 | 0.2 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.0 | 0.2 | GO:0040031 | snRNA modification(GO:0040031) |
0.0 | 0.2 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.0 | 0.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.1 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
0.0 | 0.9 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.0 | 0.2 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.0 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
0.0 | 0.0 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.0 | 0.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.1 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.0 | 0.1 | GO:0035627 | ceramide transport(GO:0035627) |
0.0 | 0.2 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.0 | 1.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.1 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.0 | 0.2 | GO:0031427 | response to methotrexate(GO:0031427) |
0.0 | 0.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.0 | 0.1 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.0 | 0.3 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.0 | 0.5 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 1.1 | GO:0032648 | regulation of interferon-beta production(GO:0032648) |
0.0 | 0.4 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.0 | 0.1 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.0 | 0.7 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.2 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
0.0 | 0.4 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.2 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.1 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.0 | 0.2 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.0 | 0.2 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.0 | 0.1 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.0 | 0.1 | GO:1990743 | protein sialylation(GO:1990743) |
0.0 | 0.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.3 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.0 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.0 | 0.1 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.0 | 0.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.0 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.0 | 0.1 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.0 | 0.1 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.0 | 0.1 | GO:0070166 | enamel mineralization(GO:0070166) |
0.0 | 0.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.0 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.0 | 0.2 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.0 | 0.0 | GO:0035696 | monocyte extravasation(GO:0035696) |
0.0 | 0.0 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.1 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.0 | 0.1 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
0.0 | 0.0 | GO:1902804 | negative regulation of synaptic vesicle transport(GO:1902804) |
0.0 | 0.0 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.0 | 0.1 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.0 | 0.4 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.0 | 0.5 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 0.3 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.0 | 0.3 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.1 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
0.0 | 0.2 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.0 | 0.0 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
0.0 | 0.0 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.0 | 0.1 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.1 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
0.0 | 0.2 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.0 | 0.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.5 | GO:0007398 | ectoderm development(GO:0007398) |
0.0 | 0.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.0 | 0.4 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.0 | 0.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.3 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.1 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.0 | 0.0 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.0 | 0.2 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.0 | 0.2 | GO:1903350 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
0.0 | 0.1 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.0 | 0.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.0 | 0.7 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.1 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.0 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.0 | 0.8 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.0 | 0.2 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.0 | 0.2 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.0 | 0.3 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.0 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.0 | 0.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.0 | 0.0 | GO:0021764 | amygdala development(GO:0021764) |
0.0 | 0.0 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.0 | 0.1 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.0 | 0.8 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.0 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.0 | GO:0044819 | mitotic G1/S transition checkpoint(GO:0044819) |
0.0 | 0.7 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.0 | 0.3 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.0 | 0.1 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
0.0 | 0.2 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.0 | 0.2 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.0 | 0.1 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.0 | 3.1 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.0 | 0.4 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.4 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 0.0 | GO:2000371 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
0.0 | 0.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.3 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.0 | 0.1 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) |
0.0 | 0.6 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.0 | 0.3 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.1 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.0 | 0.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.0 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.0 | 0.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.0 | 0.3 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
0.0 | 0.2 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.1 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.1 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.1 | GO:0071422 | succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
0.0 | 0.2 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.4 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.1 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.0 | 0.2 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.0 | 0.4 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.0 | 0.0 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
0.0 | 0.1 | GO:1903867 | extraembryonic membrane development(GO:1903867) |
0.0 | 0.3 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.2 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.0 | 0.1 | GO:0034552 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.0 | 0.6 | GO:0009268 | response to pH(GO:0009268) |
0.0 | 1.0 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.0 | 1.0 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.1 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.0 | 0.0 | GO:0097187 | dentinogenesis(GO:0097187) |
0.0 | 0.4 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.0 | 0.1 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) |
0.0 | 0.0 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.0 | 0.2 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.0 | 0.1 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.0 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) |
0.0 | 0.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.1 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.0 | 0.1 | GO:0002159 | desmosome assembly(GO:0002159) |
0.0 | 0.2 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.0 | 0.4 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.1 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.0 | 0.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 0.1 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
0.0 | 0.2 | GO:0001554 | luteolysis(GO:0001554) |
0.0 | 0.1 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.0 | 0.2 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
0.0 | 0.2 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.0 | 0.4 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.4 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.1 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.0 | 0.2 | GO:0098927 | vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.0 | 0.3 | GO:0048265 | response to pain(GO:0048265) |
0.0 | 0.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.1 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.0 | 0.0 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.0 | 0.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.0 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.0 | 0.4 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.0 | 0.8 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 0.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.2 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
0.0 | 0.2 | GO:0002467 | germinal center formation(GO:0002467) |
0.0 | 0.0 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.0 | 0.1 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.0 | 0.1 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.0 | 0.1 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.0 | 0.0 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.0 | 0.3 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.0 | 0.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.0 | 0.1 | GO:0006991 | response to sterol depletion(GO:0006991) |
0.0 | 0.0 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.0 | 0.0 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.0 | 0.1 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.0 | 0.1 | GO:0006868 | glutamine transport(GO:0006868) |
0.0 | 0.0 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.0 | 0.1 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.0 | 0.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.1 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
0.0 | 0.1 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.0 | 0.0 | GO:0036451 | cap mRNA methylation(GO:0036451) |
0.0 | 0.0 | GO:0016598 | protein arginylation(GO:0016598) |
0.0 | 0.0 | GO:0030576 | Cajal body organization(GO:0030576) |
0.0 | 0.0 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
0.0 | 0.0 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.0 | 0.2 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.0 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.0 | 0.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.1 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.0 | 0.0 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.0 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.1 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.0 | 0.0 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.0 | 0.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.0 | GO:0046671 | negative regulation of retinal cell programmed cell death(GO:0046671) |
0.0 | 0.1 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
0.0 | 0.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.0 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.0 | 0.5 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.2 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.1 | GO:0044252 | negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.0 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.1 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 0.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.0 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.0 | 0.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.3 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.1 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.0 | 0.0 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.0 | 0.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.0 | 0.0 | GO:0097298 | regulation of nucleus size(GO:0097298) |
0.0 | 0.1 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
0.0 | 0.2 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 0.1 | GO:0015824 | proline transport(GO:0015824) proline transmembrane transport(GO:0035524) |
0.0 | 0.0 | GO:0044691 | tooth eruption(GO:0044691) |
0.0 | 0.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.2 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.0 | 0.4 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.0 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
0.0 | 0.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.2 | GO:0051298 | centrosome duplication(GO:0051298) |
0.0 | 0.0 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.0 | 0.1 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.0 | 0.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.0 | GO:0007525 | somatic muscle development(GO:0007525) |
0.0 | 0.2 | GO:0097503 | sialylation(GO:0097503) |
0.0 | 0.0 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.0 | 0.2 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.0 | 0.1 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.0 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.3 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
0.0 | 0.1 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.0 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.0 | 0.1 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.0 | 0.1 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.0 | 0.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 0.1 | GO:0010524 | positive regulation of calcium ion transport into cytosol(GO:0010524) |
0.0 | 0.1 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.0 | 0.1 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 0.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.2 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.0 | 0.1 | GO:0035864 | response to potassium ion(GO:0035864) |
0.0 | 0.1 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.0 | 0.0 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.0 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.1 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.0 | 0.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 3.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.6 | 1.7 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.5 | 1.5 | GO:0097444 | spine apparatus(GO:0097444) |
0.4 | 1.2 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
0.4 | 1.2 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.4 | 1.2 | GO:0060187 | cell pole(GO:0060187) |
0.4 | 1.2 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.4 | 1.8 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.3 | 5.6 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.3 | 1.3 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.3 | 4.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.3 | 0.9 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.3 | 1.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.3 | 1.0 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.3 | 2.5 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.2 | 1.9 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
0.2 | 13.3 | GO:0060170 | ciliary membrane(GO:0060170) |
0.2 | 1.2 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.2 | 0.2 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
0.2 | 3.7 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 0.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.2 | 1.1 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 0.7 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.2 | 0.2 | GO:0098855 | HCN channel complex(GO:0098855) |
0.2 | 1.5 | GO:0001739 | sex chromatin(GO:0001739) |
0.2 | 3.5 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.2 | 2.3 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.2 | 0.8 | GO:0035363 | histone locus body(GO:0035363) |
0.2 | 1.5 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.2 | 0.7 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 0.3 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.2 | 2.4 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 0.5 | GO:0005592 | collagen type XI trimer(GO:0005592) |
0.2 | 0.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 1.0 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 0.8 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 3.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 0.5 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.2 | 0.6 | GO:0099522 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
0.1 | 2.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 3.7 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 3.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.4 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.7 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 0.4 | GO:1990597 | parallel fiber(GO:1990032) AIP1-IRE1 complex(GO:1990597) |
0.1 | 1.0 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 1.0 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 0.4 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.1 | 5.0 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 1.0 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 4.0 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 0.9 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.1 | GO:0044317 | rod spherule(GO:0044317) |
0.1 | 0.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 2.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.9 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 0.5 | GO:0034657 | GID complex(GO:0034657) |
0.1 | 0.3 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.1 | 2.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.8 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 1.1 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 1.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.5 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.1 | 0.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 0.9 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 1.5 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 0.8 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 2.4 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 1.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.6 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.1 | 1.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 1.3 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.8 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.5 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 3.6 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.8 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 0.5 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.1 | 0.6 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 0.5 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 1.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.3 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.1 | 0.4 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
0.1 | 0.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 1.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 3.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.3 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) gamma-tubulin small complex(GO:0008275) |
0.1 | 0.6 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 1.3 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.6 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 6.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.2 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
0.1 | 0.2 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.1 | 0.2 | GO:0035101 | FACT complex(GO:0035101) |
0.1 | 1.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.2 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 0.4 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 0.4 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.2 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.1 | 0.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 0.7 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 0.8 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.8 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.8 | GO:0033643 | host cell part(GO:0033643) |
0.1 | 0.7 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.1 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.1 | 0.2 | GO:0098830 | presynaptic endosome(GO:0098830) |
0.1 | 0.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.3 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.5 | GO:0038201 | TOR complex(GO:0038201) |
0.1 | 0.3 | GO:0097513 | myosin II filament(GO:0097513) |
0.1 | 0.3 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.5 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 1.3 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 0.3 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 1.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 0.5 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 1.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 1.9 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.3 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.2 | GO:0005745 | m-AAA complex(GO:0005745) |
0.1 | 2.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.2 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.1 | 0.3 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 0.6 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.1 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
0.1 | 0.9 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 1.4 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.5 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 0.4 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.1 | 0.2 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 0.6 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.2 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
0.1 | 0.2 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.1 | 0.5 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.9 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.1 | 0.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.3 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 2.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.1 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 0.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.3 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.2 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
0.1 | 0.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.1 | GO:0030689 | Noc complex(GO:0030689) |
0.0 | 0.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.0 | 0.3 | GO:0070847 | core mediator complex(GO:0070847) |
0.0 | 1.7 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.2 | GO:0044327 | dendritic spine head(GO:0044327) |
0.0 | 3.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.1 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.0 | 0.1 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 0.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.5 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 0.2 | GO:0032584 | growth cone membrane(GO:0032584) |
0.0 | 1.5 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.9 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.4 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.0 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.0 | 0.4 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.0 | 0.2 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.0 | 1.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 1.2 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 1.1 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 1.2 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.2 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.3 | GO:0097443 | sorting endosome(GO:0097443) |
0.0 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.0 | GO:0034455 | t-UTP complex(GO:0034455) |
0.0 | 1.0 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.0 | 1.0 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.2 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.0 | 2.6 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 0.8 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.1 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
0.0 | 1.1 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.0 | 1.7 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.5 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.2 | GO:0071953 | elastic fiber(GO:0071953) |
0.0 | 0.3 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.0 | 1.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.7 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.1 | GO:1990005 | granular vesicle(GO:1990005) |
0.0 | 2.0 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.1 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.1 | GO:0097454 | Schwann cell microvillus(GO:0097454) cytoplasmic side of apical plasma membrane(GO:0098592) |
0.0 | 0.2 | GO:1990130 | Iml1 complex(GO:1990130) |
0.0 | 1.7 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 1.8 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.2 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.0 | 0.6 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 1.4 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.3 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.0 | 0.3 | GO:0070461 | SAGA-type complex(GO:0070461) |
0.0 | 0.0 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.0 | 0.5 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.0 | 1.8 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.3 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.1 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.0 | 0.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 6.1 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.0 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 0.6 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.2 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 0.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 0.5 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 4.9 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.5 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 1.4 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.2 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.1 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.3 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.1 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.0 | 0.7 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.0 | 0.1 | GO:0033269 | internode region of axon(GO:0033269) |
0.0 | 0.1 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.0 | 0.5 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.3 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.1 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.0 | 0.1 | GO:0000811 | GINS complex(GO:0000811) |
0.0 | 0.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.2 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.0 | 0.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.0 | 2.4 | GO:0060076 | excitatory synapse(GO:0060076) |
0.0 | 0.6 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.3 | GO:0097386 | glial cell projection(GO:0097386) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.2 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.3 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 6.4 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.5 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.7 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.1 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.0 | 2.4 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 0.2 | GO:0070187 | telosome(GO:0070187) |
0.0 | 0.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.0 | 0.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.0 | 0.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.0 | 0.1 | GO:0035859 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
0.0 | 0.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.2 | GO:0032797 | SMN complex(GO:0032797) |
0.0 | 0.1 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 0.2 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.2 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 2.1 | GO:0097060 | synaptic membrane(GO:0097060) |
0.0 | 0.8 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.3 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.0 | 0.3 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.0 | GO:0043511 | inhibin complex(GO:0043511) |
0.0 | 0.2 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 0.1 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.0 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 0.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 1.2 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 1.6 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.0 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
0.0 | 0.0 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.0 | 0.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 0.0 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.0 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
0.0 | 0.0 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 0.0 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.0 | GO:0097342 | ripoptosome(GO:0097342) |
0.0 | 0.0 | GO:0031010 | ISWI-type complex(GO:0031010) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 14.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.8 | 2.5 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.8 | 2.5 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.8 | 3.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.7 | 2.6 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.6 | 1.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.6 | 1.8 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
0.5 | 2.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.5 | 1.5 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.5 | 3.0 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.5 | 2.5 | GO:0038132 | neuregulin binding(GO:0038132) |
0.5 | 4.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.4 | 2.2 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.4 | 2.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.4 | 1.5 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.4 | 1.1 | GO:0005119 | smoothened binding(GO:0005119) |
0.4 | 2.2 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.4 | 2.9 | GO:0071253 | connexin binding(GO:0071253) |
0.4 | 1.4 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.4 | 2.8 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.3 | 2.3 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.3 | 0.9 | GO:0015292 | uniporter activity(GO:0015292) |
0.3 | 0.9 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.3 | 0.9 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) |
0.3 | 6.8 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.3 | 2.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.3 | 0.6 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.3 | 0.8 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
0.3 | 2.2 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.3 | 1.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 3.1 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.3 | 0.8 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.3 | 1.3 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.3 | 1.0 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.2 | 1.5 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.2 | 0.7 | GO:0031249 | denatured protein binding(GO:0031249) |
0.2 | 3.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.2 | 1.8 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.2 | 0.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 0.6 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.2 | 0.6 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.2 | 0.6 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
0.2 | 6.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 5.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 1.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 0.8 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.2 | 0.8 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.2 | 1.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.2 | 0.6 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.2 | 0.6 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.2 | 2.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 1.2 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 2.9 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 0.2 | GO:0031208 | POZ domain binding(GO:0031208) |
0.2 | 0.6 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 0.6 | GO:0004359 | glutaminase activity(GO:0004359) |
0.2 | 0.7 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.2 | 0.7 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.2 | 0.7 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.2 | 0.5 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.2 | 0.7 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
0.2 | 0.5 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.2 | 1.7 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.2 | 0.5 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
0.2 | 0.7 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.2 | 0.9 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 0.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.2 | 2.9 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 0.9 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.2 | 0.5 | GO:0035939 | microsatellite binding(GO:0035939) |
0.2 | 1.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 6.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 0.2 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.2 | 1.0 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 0.5 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.2 | 0.7 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.2 | 4.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 2.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 0.5 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 1.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 1.7 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 1.6 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 0.3 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.1 | 1.2 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.4 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 1.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 3.5 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 3.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 2.1 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 1.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.5 | GO:0043404 | corticotrophin-releasing factor receptor activity(GO:0015056) corticotropin-releasing hormone receptor activity(GO:0043404) |
0.1 | 2.3 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.1 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.1 | 0.5 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 0.7 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 0.3 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.1 | 1.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 0.5 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 1.1 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.1 | 0.9 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.1 | 0.2 | GO:0016890 | site-specific endodeoxyribonuclease activity, specific for altered base(GO:0016890) |
0.1 | 0.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 2.1 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.6 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.2 | GO:0001565 | phorbol ester receptor activity(GO:0001565) |
0.1 | 0.5 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.1 | 0.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 7.3 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 2.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.5 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 1.0 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 1.9 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.8 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.3 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.4 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.3 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
0.1 | 1.3 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 2.4 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.4 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.3 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.1 | 0.7 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.3 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.1 | 1.9 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.1 | 0.5 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.1 | 0.4 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.7 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) |
0.1 | 0.5 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.3 | GO:0008254 | 3'-nucleotidase activity(GO:0008254) |
0.1 | 0.6 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.9 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
0.1 | 1.7 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 0.5 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 0.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.4 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 2.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 1.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.3 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 2.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 1.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 0.3 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.1 | 0.6 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 1.0 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.8 | GO:0098879 | structural constituent of postsynaptic specialization(GO:0098879) structural constituent of postsynaptic density(GO:0098919) |
0.1 | 1.9 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.6 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 0.3 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.1 | 1.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.4 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 0.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 2.7 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.1 | 0.3 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
0.1 | 7.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 1.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.6 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.4 | GO:0001729 | ceramide kinase activity(GO:0001729) |
0.1 | 0.4 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.3 | GO:0001007 | transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
0.1 | 1.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.6 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.5 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.4 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 4.0 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.1 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.3 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 0.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.3 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 1.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 1.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 2.2 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 1.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 4.8 | GO:0004004 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) |
0.1 | 0.2 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.1 | 0.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 1.0 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 3.1 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.6 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 0.4 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 0.5 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.3 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 0.3 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.1 | 0.9 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.3 | GO:0004488 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.1 | 0.7 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 1.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.2 | GO:0030977 | taurine binding(GO:0030977) |
0.1 | 0.1 | GO:1904315 | transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.1 | 0.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.7 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.8 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 0.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.7 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.3 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.1 | 0.4 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.1 | 0.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.1 | 0.2 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.1 | 0.5 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 0.3 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.6 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 6.5 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.2 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.1 | 0.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 1.4 | GO:0071949 | FAD binding(GO:0071949) |
0.1 | 0.3 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 0.7 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.3 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.2 | GO:0030626 | U12 snRNA binding(GO:0030626) |
0.1 | 3.1 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 1.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.3 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.1 | 0.6 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 1.7 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.2 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.1 | 0.3 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.1 | 0.2 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.2 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.1 | 0.2 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.2 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.1 | 0.2 | GO:0004040 | amidase activity(GO:0004040) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.2 | GO:0050497 | methylthiotransferase activity(GO:0035596) transferase activity, transferring alkylthio groups(GO:0050497) |
0.1 | 0.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 1.0 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 1.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.7 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.2 | GO:0009384 | N-acylmannosamine kinase activity(GO:0009384) |
0.1 | 2.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.3 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.1 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.2 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.4 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.1 | 1.2 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 0.2 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.1 | 4.2 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.0 | 0.2 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.0 | 0.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.1 | GO:0034512 | box C/D snoRNA binding(GO:0034512) |
0.0 | 0.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.2 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.0 | 0.2 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.0 | 0.1 | GO:0015489 | polyamine transmembrane transporter activity(GO:0015203) putrescine transmembrane transporter activity(GO:0015489) |
0.0 | 0.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.1 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.0 | 0.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.0 | 0.4 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.2 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 0.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 0.4 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.3 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 0.0 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.0 | 2.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.2 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.0 | 0.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.2 | GO:0005234 | ionotropic glutamate receptor activity(GO:0004970) extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.0 | 0.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.3 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 3.1 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 1.7 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.0 | 0.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.2 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.3 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 8.8 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.2 | GO:0052796 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.7 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.2 | GO:0034046 | poly(G) binding(GO:0034046) |
0.0 | 0.3 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.1 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.3 | GO:0016594 | glycine binding(GO:0016594) |
0.0 | 0.2 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.0 | 0.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.0 | 0.1 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.0 | 0.4 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.1 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.0 | 0.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.1 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.0 | 3.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.2 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 2.7 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 2.3 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.0 | 0.8 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.0 | 0.1 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.0 | 0.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.6 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.1 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.0 | 2.0 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.1 | GO:0031714 | C5a anaphylatoxin chemotactic receptor binding(GO:0031714) |
0.0 | 1.6 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.1 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.0 | 3.1 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 0.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 6.9 | GO:0061659 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.2 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.0 | 0.3 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.0 | 0.3 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 3.6 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.0 | 0.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.8 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 3.5 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.6 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.1 | GO:0016433 | rRNA (adenine) methyltransferase activity(GO:0016433) |
0.0 | 0.1 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.0 | 0.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.6 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.1 | GO:0008486 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.0 | 0.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.1 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.0 | 0.1 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.1 | GO:0000832 | inositol-1,3,4,5,6-pentakisphosphate kinase activity(GO:0000827) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.0 | 0.9 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.2 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.1 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.0 | 1.0 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 0.0 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.0 | 0.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.0 | 0.2 | GO:0050543 | icosanoid binding(GO:0050542) icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.0 | 1.1 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.6 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.0 | 0.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.2 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.0 | 0.1 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.0 | 0.4 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.1 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.0 | 0.6 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.1 | GO:0030613 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.0 | 0.3 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 0.1 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.0 | 0.1 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.0 | 0.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.0 | 0.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.0 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 0.1 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 0.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.0 | 0.0 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.2 | GO:0010851 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.0 | 0.1 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.3 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.2 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 0.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 0.3 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.3 | GO:0033558 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
0.0 | 0.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.1 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.0 | 0.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.1 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.0 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.1 | GO:0004825 | methionine-tRNA ligase activity(GO:0004825) |
0.0 | 0.4 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.4 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.0 | 0.3 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 0.0 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.0 | 0.1 | GO:0008396 | oxysterol 7-alpha-hydroxylase activity(GO:0008396) |
0.0 | 0.6 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.2 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.1 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 0.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.2 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.0 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 0.1 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.0 | 0.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.0 | GO:0046030 | inositol trisphosphate phosphatase activity(GO:0046030) |
0.0 | 0.1 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.0 | 0.0 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.0 | 0.1 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.0 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.1 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.1 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.0 | 0.0 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.1 | GO:0051870 | methotrexate binding(GO:0051870) |
0.0 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.0 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.2 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.0 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.0 | 0.6 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 0.1 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.0 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.1 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.0 | 1.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.0 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.5 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 0.0 | GO:0003842 | 1-pyrroline-5-carboxylate dehydrogenase activity(GO:0003842) |
0.0 | 0.1 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.0 | 0.1 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.0 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.0 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.0 | 0.0 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 1.1 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.0 | 0.1 | GO:0030169 | signaling pattern recognition receptor activity(GO:0008329) low-density lipoprotein particle binding(GO:0030169) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.0 | GO:0000991 | transcription factor activity, core RNA polymerase II binding(GO:0000991) |
0.0 | 0.1 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 4.0 | GO:0004672 | protein kinase activity(GO:0004672) |
0.0 | 0.0 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.0 | 0.0 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.0 | 0.1 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.0 | 0.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.1 | GO:0030695 | GTPase regulator activity(GO:0030695) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 16.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 4.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 2.9 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 6.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 6.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 3.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 1.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 1.9 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 0.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 1.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 2.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 2.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 2.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 5.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 0.8 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 1.4 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 2.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 3.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 2.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 3.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 2.8 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 4.0 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 1.8 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 2.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 1.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 3.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 3.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 1.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 3.8 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.5 | ST STAT3 PATHWAY | STAT3 Pathway |
0.1 | 1.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.7 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 0.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.5 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 1.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 1.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 1.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 0.6 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 1.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 2.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.8 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.7 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.9 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 1.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.1 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 1.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.3 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 1.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.9 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 1.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 4.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 1.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.6 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.4 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.5 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 3.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.8 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.4 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.2 | PID FGF PATHWAY | FGF signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 5.8 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.3 | 3.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 4.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 4.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.2 | 3.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 0.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 2.3 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.2 | 2.5 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 3.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 8.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 0.7 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 5.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 3.8 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.2 | 4.8 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.2 | 2.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 3.1 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 3.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 3.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 2.7 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.2 | 2.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 2.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 0.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.2 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.2 | 0.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 1.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 1.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 0.8 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 1.7 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 0.5 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 3.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 1.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 0.3 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.1 | 0.8 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 4.5 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 2.9 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 2.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 3.0 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.1 | 1.5 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.1 | 5.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 0.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 0.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 0.7 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 1.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 1.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 3.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 3.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 0.5 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 0.7 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 0.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 1.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 0.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 0.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 0.6 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.6 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.1 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 1.6 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.1 | 1.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 1.3 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.1 | 0.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.5 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.6 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 1.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.4 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 1.3 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.6 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.5 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.4 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.7 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.0 | 0.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 0.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.2 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.0 | 0.3 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 0.6 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.1 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.0 | 0.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.4 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 0.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.0 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.0 | 0.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 1.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 2.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.1 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.0 | 0.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.9 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 1.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.3 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.2 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.7 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.2 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.8 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.2 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 0.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.3 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.0 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.3 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.1 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.2 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.5 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |